Targeted Chemotherapy
(Molecular pathway and angiogenesis inhibitors, vascular disrupters)
|
Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours (Canada)
http://www.clinicaltrials.gov/ct2/show/NCT00566410?term=Dichloroacetate&rank=1
|
Phase I SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors (Canada)
http://www.clinicaltrials.gov/ct/show/NCT00504296?order=100
|
Phase I Study of PXD101 in Patients With Advanced Solid Tumors
http://www.clinicaltrials.gov/ct/show/NCT00413075?order=1
|
A Phase I Study of PXD101 Alone and in Combination With 5-FU in Patients With Advanced Solid Tumors
http://www.clinicaltrials.gov/ct/show/NCT00413322?order=2
|
Phase I Study of BMS-354825 in Patients With Solid Tumors
http://www.clinicaltrials.gov/ct/show/NCT00339144?order=17
|
Phase II Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma (Netherlands)
http://clinicaltrials.gov/show/NCT00410462
|
Phase II BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas (Italy)
http://www.clinicaltrials.gov/ct/show/NCT00406601?order=61
|
Phase II Pemetrexed in Patients With Soft Tissue Sarcoma (Germany)
http://www.clinicaltrials.gov/ct/show/NCT00427466?order=48
|
Phase II VEGF Trap in Treating Patients With Recurrent or Metastatic Gynecologic Soft Tissue Sarcoma
http://www.clinicaltrials.gov/ct/show/NCT00390234?order=10
|
Phase III Deforolimus (AP23573) in Treatment of Sarcoma - SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Deforolimus) Study
http://www.clinicaltrials.gov/ct/show/NCT00538239?order=1
|
Cytotoxic Chemotherapy
(Kills all fast growing cells – healthy & cancerous)
|
Phase I E7389 and Gemcitabine in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery
http://www.clinicaltrials.gov/ct/show/NCT00410553?order=2
|
Phase I and II Trial With TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients
http://www.clinicaltrials.gov/ct/show/NCT00289809?order=91
|
Phase II Pemetrexed in Patients With Soft Tissue Sarcoma (Germany)
http://www.clinicaltrials.gov/ct/show/NCT00427466?order=40
|
Phase II Study of E7389 in Patients With Advanced and/or Metastatic Soft Tissue Sarcoma
http://www.cancer.gov/clinicaltrials/EORTC-62052
|
Phase II Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)
http://www.clinicaltrials.gov/ct/show/NCT00204568?order=52
|
Phase II Study of Vinorelbine + Cyclofosfamide Among Patients With Refractory Tumors or in Relapse
http://www.clinicaltrials.gov/ct/show/NCT00180947?order=82
|
Phase II Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma
http://www.clinicaltrials.gov/ct/show/NCT00227669?order=1
|
Phase III Randomized Phase 3 Non Metastatic Uterine Sarcomas
http://www.clinicaltrials.gov/ct/show/NCT00162721?order=76
|
Phase III Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
http://www.clinicaltrials.gov/ct/show/NCT00061984?order=6
|
Immunotherapy
(Vaccines, viral or gene therapy)
|
Phase I/II Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors (Israel)
http://www.clinicaltrials.gov/ct/show/NCT00148993?order=4
|
Phase II Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With rIL-2 for Metastatic Solid Tumors (Israel)
http://www.clinicaltrials.gov/ct/show/NCT00149006?order=10
|
Phase II Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host (Israel)
http://www.clinicaltrials.gov/ct/show/NCT00149032?order=12
|
Phase II A Novel Vaccine for the Treatment of MUC1-Expressing Tumor Malignancies (Israel)
http://www.clinicaltrials.gov/ct/show/NCT00162500?order=8
|
Interventional Radiology
(RFA, cryoablation, ultrasound, cyberknife)
|
Phase II IMRT Lower Limb Soft Tissue Sarcoma
http://www.clinicaltrials.gov/ct/show/NCT00188175?order=59
|
Stem Cell
|
|
Combined Methods
(Chemo + radiation + surgery, etc.)
|
Phase I-II Trial of Sorafenib in Combination With Ifosfamide in SoftTissue Sarcoma (Spain)
http://www.clinicaltrials.gov/ct/show/NCT00541840?order=205
|
Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas in First Line of Treatment for the Metastatic Disease (NGR011) (Italy)
http://www.clinicaltrials.gov/ct/show/NCT00484341?order=67
|
Other
|
The Exceptional Patient in Cancer Care
http://www.clinicaltrials.gov/ct/show/NCT00543153?order=42
|
An Adequate Cost Effective Follow Up Protocol For Bone & Soft Tissue Sarcomas - A Prospective Randomized Trial (India)
http://www.clinicaltrials.gov/ct/show/NCT00384735?order=79
|
Biobank Sarcoma: Storing Blood for Analysis of DNA and Protein of Patients With Sarcoma (Netherlands)
http://www.clinicaltrials.gov/ct/show/NCT00181480?order=31
|
